Sunday June 7, 2020

The Sunday Interview: Amryt CEO Joe Wiley

Joe Wiley is a doctor with a background in finance, a noteworthy combination that has helped his pharma firm Amryt buck the boom and bust biotech model

Ian Guider

Markets Editor

@ianguider
17th May, 2020
Joe Wiley, chief executive of Amryt Pharma

In brief

Name: Joe Wiley, chief executive of Amryt Pharma

Age: 49

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Related Stories

Donald Trump’s branding of Antifa activists as domestic terrorists aims to distract attention from the socio-economic and racial factors that contributed to George Floyd’s murder

Barry J Whyte | 8 hours ago

Once a dashing out-half for club and country, Felipe Contepomi is today overseeing the development of the new generation at Leinster Rugby – but the medical man has a strong fall-back plan if it all goes wrong

Emmet Ryan | 8 hours ago

Meaghers Pharmacy Group owner Oonagh O’Hagan says Covid-19 has fast-tracked irreversible reforms in how pharmacies deliver healthcare to the community

Daniel Murray | 1 week ago